Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: Experiences from (radio) immunotherapy

被引：10
作者：
Brouwers, Adrienne H. [1 ]
Mulders, Peter F. A. [2 ]
Oyen, Wim J. G. [3 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9700 AB Groningen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 22期
关键词：
D O I：
10.1200/JCO.2008.17.6073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3808 / 3809
页数：2
相关论文
共 14 条
[1]   A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma [J].
Bleumer, I ;
Oosterwijk, E ;
Oosterwijk-Wakka, JC ;
Völler, MCW ;
Melchior, S ;
Warnaar, SO ;
Mala, C ;
Beck, J ;
Mulders, PFA .
JOURNAL OF UROLOGY, 2006, 175 (01) :57-62
[2]   A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients [J].
Bleumer, I ;
Knuth, A ;
Oosterwijk, E ;
Hofmann, R ;
Varga, Z ;
Lamers, C ;
Kruit, W ;
Melchior, S ;
Mala, C ;
Ullrich, S ;
De Mulder, P ;
Mulders, PFA ;
Becks, J .
BRITISH JOURNAL OF CANCER, 2004, 90 (05) :985-990
[3]   Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma [J].
Brouwers, AH ;
Mulders, PFA ;
de Mulder, PHM ;
van den Broek, WJM ;
Buijs, WCAM ;
Mala, C ;
Joosten, FBM ;
Oosterwijk, E ;
Boerman, OC ;
Corstens, FHM ;
Oyen, WJG .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6540-6548
[4]  
Brouwers AH, 2003, CLIN CANCER RES, V9, p3953S
[5]   131I-cG250 monoclonal antibody immunoscintigraphy versus [18F]FDG-PET imaging in patients with metastatic renal cell carcinoma:: a comparative study [J].
Brouwers, AH ;
Dörr, U ;
Lang, O ;
Boerman, OC ;
Oyen, WJG ;
Steffens, MG ;
Oosterwijk, E ;
Mergenthaler, HG ;
Bihl, H ;
Corstens, FHM .
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (03) :229-236
[6]   Prognostic value of carbonic anhydrase IX and Ki67 as predictors of survival for renal clear cell carcinoma [J].
Bui, MHT ;
Visapaa, H ;
Seligson, D ;
Kim, H ;
Han, KR ;
Huang, Y ;
Horvath, S ;
Stanbridge, EJ ;
Palotie, A ;
Figlin, RA ;
Belldegrun, AS .
JOURNAL OF UROLOGY, 2004, 171 (06) :2461-2466
[7]  
Bui MHT, 2003, CLIN CANCER RES, V9, P802
[8]   Expression of hypoxia-lnducible cell-surface transmembrane carbonic anhydrases in human cancer [J].
Ivanov, S ;
Liao, SY ;
Ivanova, A ;
Danilkovitch-Miagkova, A ;
Tarasova, N ;
Weirich, G ;
Merrill, MJ ;
Proescholdt, MA ;
Oldfield, EH ;
Lee, J ;
Zavada, J ;
Waheed, A ;
Sly, W ;
Lerman, MI ;
Stanbridge, EJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :905-919
[9]   Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma [J].
Leibovich, Bradley C. ;
Sheinin, Yuri ;
Lohse, Christine M. ;
Thompson, R. Houston ;
Cheville, John C. ;
Zavada, Jan ;
Kwon, Eugene D. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4757-4764
[10]  
Li GR, 2001, CLIN CANCER RES, V7, P89
12